VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 1,870,522 Value ($000) $21,006 Avg Close — Range —
Q1 2025
Shares 131,773 Value ($000) $602 Avg Close — Range —
Q4 2024
Shares 139,789 Value ($000) $788 Avg Close — Range —
Q3 2024
Shares 164,127 Value ($000) $794 Avg Close — Range —
Q2 2024
Shares 106,702 Value ($000) $521 Avg Close — Range —
Q1 2024
Shares 291,984 Value ($000) $3,878 Avg Close — Range —
Q4 2023
Shares 203,351 Value ($000) $2,835 Avg Close — Range —
Q3 2023
Shares 83,263 Value ($000) $1,104 Avg Close — Range —
Q2 2023
Shares 88,074 Value ($000) $1,651 Avg Close — Range —
Q1 2023
Shares 90,835 Value ($000) $1,310 Avg Close — Range —
Q4 2022
Shares 243,774 Value ($000) $4,717 Avg Close — Range —
Q3 2022
Shares 33,703 Value ($000) $1,157 Avg Close — Range —
Q2 2022
Shares 150 Value ($000) $2 Avg Close — Range —
Q1 2022
Shares 106,251 Value ($000) $2,424 Avg Close — Range —
Q4 2021
Shares 24,330 Value ($000) $897 Avg Close — Range —
Q3 2021
Shares 3,300 Value ($000) $155 Avg Close — Range —
Q2 2021
Shares 1,531 Value ($000) $92 Avg Close — Range —